Fig. 4
From: Glaucocalyxin A delays the progression of OA by inhibiting NF-κB and MAPK signaling pathways
GLA impacted the expression of associated gene phenotypes via the NF-κB signaling pathway, according to functional recovery experiments. A Western blot and quantification analysis confirmed that BA, an NF-κB signaling pathway activator, may influence the expression levels of COX2, INOS, MMP13, SOX9, and COL2A1 in chondrocytes. B Western blot and quantification analysis cinfirmed that BA, and activator of the NF-κB signaling pathway, may influence p65 and p-p65 expression levels in chondrocytes